ClinVar Miner

Submissions for variant NM_025137.4(SPG11):c.6258G>T (p.Leu2086=)

gnomAD frequency: 0.00781  dbSNP: rs150761878
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 12
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Genetic Services Laboratory, University of Chicago RCV000118406 SCV000152806 uncertain significance not provided 2014-03-06 criteria provided, single submitter clinical testing
Illumina Laboratory Services, Illumina RCV000461243 SCV000391269 uncertain significance Hereditary spastic paraplegia 11 2018-01-13 criteria provided, single submitter clinical testing This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease.
Labcorp Genetics (formerly Invitae), Labcorp RCV000461243 SCV000557278 benign Hereditary spastic paraplegia 11 2024-02-01 criteria provided, single submitter clinical testing
GeneDx RCV000609000 SCV000714007 benign not specified 2017-10-31 criteria provided, single submitter clinical testing This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center RCV000461243 SCV000745403 likely benign Hereditary spastic paraplegia 11 2017-06-28 criteria provided, single submitter clinical testing
Athena Diagnostics RCV000118406 SCV000844027 benign not provided 2018-03-29 criteria provided, single submitter clinical testing
Genome Diagnostics Laboratory, The Hospital for Sick Children RCV001847726 SCV002105748 likely benign Hereditary spastic paraplegia 2021-11-15 criteria provided, single submitter clinical testing
CeGaT Center for Human Genetics Tuebingen RCV000118406 SCV002497771 likely benign not provided 2024-08-01 criteria provided, single submitter clinical testing SPG11: BP4, BP7, BS2
Ambry Genetics RCV002362748 SCV002659494 likely benign Inborn genetic diseases 2019-07-11 criteria provided, single submitter clinical testing This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen RCV000461243 SCV000733441 likely benign Hereditary spastic paraplegia 11 no assertion criteria provided clinical testing
Genome Diagnostics Laboratory, Amsterdam University Medical Center RCV000461243 SCV000745905 likely benign Hereditary spastic paraplegia 11 2017-01-04 no assertion criteria provided clinical testing
PreventionGenetics, part of Exact Sciences RCV003915170 SCV004735707 benign SPG11-related disorder 2019-06-15 no assertion criteria provided clinical testing This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.